S1204, Viral Screening in Newly Diagnosed Cancer Patients
A Sero-Epidemiologic Survey and Cost Effectiveness Study of Screening for Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Among Newly Diagnosed Cancer Patients
3 other identifiers
observational
3,051
1 country
58
Brief Summary
The goal of this study is to estimate the prevalence of HIV, Hepatitis B and hepatitis C infection among newly diagnosed cancer patients presenting to community and academic oncology clinics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2013
Longer than P75 for all trials
58 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 29, 2013
CompletedFirst Submitted
Initial submission to the registry
September 16, 2013
CompletedFirst Posted
Study publicly available on registry
September 19, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 13, 2022
CompletedResults Posted
Study results publicly available
July 3, 2023
CompletedJuly 3, 2023
June 1, 2023
4.3 years
September 16, 2013
April 21, 2023
June 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Positive Viral Infection
An estimate of the prevalence of human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV) infection among newly diagnosed cancer participants presenting to SWOG-affiliated community and academic oncology clinics.
Up to 21 days after registration
Secondary Outcomes (7)
Presence of Important Risk Factors in Participants Tested for Previous HBV
Up to 21 days after registration
Presence of Important Risk Factors in Participants Tested for Chronic HBV
Up to 21 days after registration
Presence of Important Risk Factors in Participants Tested for HCV
Up to 21 days after registration
Presence of Important Risk Factors in Participants Tested for HIV
Up to 21 days after registration
Type of Treatment for Cancer and Virus in Participants With Positive Viral Test
60 days after registration
- +2 more secondary outcomes
Eligibility Criteria
Community and academic oncology clinics
You may qualify if:
- presenting for evaluation or treatment of a new cancer malignancy(including hematologic)
- confirmed pathologic diagnosis must be within 120 days of registration (Patients presenting for "second opinions" of confirmed malignancies are eligible, including those who have started cancer treatment at other facilities)
- at least 18 years of age
- patient must have had their blood drawn for HIV, HBV and HCV testing prior to registration (Patients who have had HIV, HBV and/or HCV testing within 60 days prior to registration and who do not wish to be retested are eligible, provided supporting documents can be obtained confirming viral test results for all three viruses. Documentation must be obtained prior to registration.
- Patients who are viral positive for either HIV, HBV, and/or HCV and who do not wish to be retested are eligible, provided documentation of viral load within 120 days prior to registration can be obtained. Note that these patients must be tested for or provide current viral load for all three viruses to be eligible. Documentation must be obtained prior to registration.)
- Patients must sign and give written informed consent in accordance with institutional and federal guidelines
- Patients must be offered the opportunity to allow their blood specimens to be banked by the SWOG Repository for future research
You may not qualify if:
- diagnosed with a malignancy other than the current malignancy within the past five years (with the exception of basal cell or squamous cell skin cancer, in situ cervical cancer, or in situ breast cancer.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SWOG Cancer Research Networklead
- National Cancer Institute (NCI)collaborator
Study Sites (58)
Kaiser Permanente Hospital
Fontana, California, 92335, United States
Kaiser Permanente - Harbor City
Harbor City, California, 90710, United States
Contra Costa Regional Medical Center
Martinez, California, 94553-3156, United States
East Bay Physicians Medical Group-Summit
Oakland, California, 94609, United States
Kaiser Permanente-Oakland
Oakland, California, 94611, United States
Desert Regional Medical Center
Palm Springs, California, 92262, United States
Kaiser Permanente - Panorama City
Panorama City, California, 91402, United States
Kaiser Permanente-Roseville
Roseville, California, 95661, United States
Kaiser Permanente-San Francisco
San Francisco, California, 94115, United States
Kaiser Permanente Medical Center-Vacaville
Vacaville, California, 95688, United States
Kaiser Permanente-Lone Tree
Lone Tree, Colorado, 80124, United States
University of Hawaii Cancer Center
Honolulu, Hawaii, 96813, United States
Tripler Army Medical Center
Honolulu, Hawaii, 96859, United States
Saint Luke's Mountain States Tumor Institute - Meridian
Meridian, Idaho, 83642, United States
Mac Neal Hospital
Berwyn, Illinois, 60402, United States
Weiss Memorial Hospital
Chicago, Illinois, 60640, United States
Hines Veterans Administration Hospital
Hines, Illinois, 60141, United States
West Suburban Medical Center
River Forest, Illinois, 60305, United States
Veteran Administration Eastern Kansas Healthcare
Leavenworth, Kansas, 66048, United States
Topeka VA Hospital
Topeka, Kansas, 66622, United States
LSU Health Baton Rouge-North Clinic
Baton Rouge, Louisiana, 70805, United States
Louisiana Hematology Oncology Associates LLC
Baton Rouge, Louisiana, 70809, United States
Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana, 70809, United States
Medical Oncology LLC
Baton Rouge, Louisiana, 70809, United States
Mary Bird Cancer Center/Saint Tammany Parish
Covington, Louisiana, 70433, United States
Women's Cancer Care-Covington
Covington, Louisiana, 70433, United States
Mary Bird Perkins Cancer Center/Terrebonne General Medical Center
Houma, Louisiana, 70360, United States
Oncology Center of The South Incorporated
Houma, Louisiana, 70360, United States
East Jefferson General Hospital
Metairie, Louisiana, 70006, United States
University Health-Conway
Monroe, Louisiana, 71202, United States
University Medical Center New Orleans
New Orleans, Louisiana, 70112, United States
Louisiana State University Health Sciences Center Shreveport
Shreveport, Louisiana, 71103, United States
North Shore Hematology Oncology Associates Inc
Slidell, Louisiana, 70458, United States
Boston Medical Center
Boston, Massachusetts, 02118, United States
Kansas City Veterans Affairs Medical Center
Kansas City, Missouri, 64128, United States
Billings Clinic Cancer Center
Billings, Montana, 59101, United States
Saint James Community Hospital and Cancer Treatment Center
Butte, Montana, 59701, United States
Columbia University/Herbert Irving Cancer Center
New York, New York, 10032, United States
Adena Regional Medical Center
Chillicothe, Ohio, 45601, United States
Columbus Oncology and Hematology Associates Inc
Columbus, Ohio, 43214, United States
Grant Medical Center
Columbus, Ohio, 43215, United States
OneHealth Marion General Hospital
Marion, Ohio, 43302, United States
Knox Community Hospital
Mount Vernon, Ohio, 43050, United States
Licking Memorial Hospital
Newark, Ohio, 43055, United States
Southern Ohio Medical Center
Portsmouth, Ohio, 45662, United States
Kaiser Permanente Northwest
Portland, Oregon, 97227, United States
Greenville Health System Cancer Institute-Andrews
Greenville, South Carolina, 29605, United States
Greenville Health System Cancer Institute-Butternut
Greenville, South Carolina, 29605, United States
Greenville Health System Cancer Institute-Faris
Greenville, South Carolina, 29605, United States
Greenville Memorial Hospital
Greenville, South Carolina, 29605, United States
Greenville Health System Cancer Institute-Eastside
Greenville, South Carolina, 29615, United States
Greenville Health System Cancer Institute-Greer
Greer, South Carolina, 29650, United States
Greenville Health System Cancer Institute-Seneca
Seneca, South Carolina, 29672, United States
Greenville Health System Cancer Institute-Spartanburg
Spartanburg, South Carolina, 29307, United States
The Don and Sybil Harrington Cancer Center
Amarillo, Texas, 79106, United States
Lyndon Baines Johnson General Hospital
Houston, Texas, 77026-1967, United States
Audie L Murphy Veterans Affairs Hospital
San Antonio, Texas, 78209, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
Biospecimen
Specimen submission is optional.
MeSH Terms
Conditions
Results Point of Contact
- Title
- Cancer Care Delivery Committee Statistician
- Organization
- SWOG Statistics and Data Management Center
Study Officials
- STUDY CHAIR
Scott D. Ramsey, M.D.
Fred Hutchinson Cancer Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2013
First Posted
September 19, 2013
Study Start
August 29, 2013
Primary Completion
January 1, 2018
Study Completion
October 13, 2022
Last Updated
July 3, 2023
Results First Posted
July 3, 2023
Record last verified: 2023-06